Antigen presentation mediated by recycling of surface HLA-DR molecules

Nature
V M PinetE O Long

Abstract

Class II histocompatibility molecules associate with peptides derived from antigens that are processed in endocytic compartments. Antigen presentation to class II-restricted T cells generally requires newly synthesized class II molecules, associated invariant chain, and HLA-DM. Exceptions to these rules have been reported, but without description of an underlying mechanism. Here we show that presentation of immunodominant epitopes in the haemagglutinin protein of influenza virus and in myelin basic protein correlates with recycling of surface HLA-DR molecules. Truncation of either one of the alpha or beta cytoplasmic tails virtually eliminated internalization of HLA-DR molecules and presentation of haemagglutinin from inactive virus particles. In contrast, the invariant chain-dependent presentation of matrix antigen from the same virus particles was unaffected by these truncations. Thus HLA-DR cytoplasmic tails are not required for the conventional presentation pathway, but jointly contribute a signal for an alternative pathway involving internalization of HLA-DR molecules.

References

Jan 1, 1991·Annual Review of Immunology·J B Rothbard, M L Gefter
Jan 1, 1994·Annual Review of Immunology·P Cresswell
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P A RocheE O Long

❮ Previous
Next ❯

Citations

Apr 29, 1998·European Journal of Immunology·V M Pinet, E O Long
Feb 28, 1998·Immunologic Research·M S Marks
Mar 31, 2000·Immunologic Research·P E JensenC T Dao
Sep 22, 2001·International Journal for Parasitology·C G Lüder, F Seeber
Jun 6, 2000·Advanced Drug Delivery Reviews·W A Marasco, Dana Jones S
May 1, 1997·Human Immunology·A B VogtG J Hämmerling
Feb 27, 2003·Journal of Autoimmunity·Viviana Marin-EstebanOlaf Rötzschke
Jan 13, 2001·Current Opinion in Immunology·C Théry, S Amigorena
Feb 1, 1996·Current Opinion in Immunology·R Busch, E D Mellins
Jun 1, 1996·Current Opinion in Immunology·A Lanzavecchia
Feb 1, 1997·Current Opinion in Immunology·M CellaA Lanzavecchia
Feb 1, 1997·Current Opinion in Immunology·J Pieters
May 29, 1998·Current Opinion in Immunology·P Pierre, I Mellman
Feb 19, 2000·Current Opinion in Immunology·R BuschE D Mellins
Mar 1, 1997·Trends in Cell Biology·R WubboltsJ Neefjes
Aug 8, 1998·Trends in Cell Biology·I MellmanR M Steinman
Apr 1, 2000·Microbes and Infection·W P Maksymowych, K P Kane
Dec 1, 2010·Immunology and Cell Biology·Ole J B LandsverkOddmund Bakke
Mar 29, 2002·Immunology·John H Robinson, Alexei A Delvig
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Nicolas LapaqueAdrian P Kelly
Nov 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kazuyuki FurutaPaul A Roche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.